Laboratorios Farmaceuticos Rovi, S.A. (LON: 0ILL)
London flag London · Delayed Price · Currency is GBP · Price in EUR
61.65
+0.25 (0.41%)
Dec 23, 2024, 5:51 PM BST

Laboratorios Farmaceuticos Rovi Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
2,6242,7881,7073,4751,8811,145
Upgrade
Market Cap Growth
28.21%63.31%-50.88%84.77%64.27%31.90%
Upgrade
Enterprise Value
2,7242,7971,6873,4151,9161,147
Upgrade
Last Close Price
51.2252.2431.3059.0332.6819.52
Upgrade
PE Ratio
19.1118.869.6427.0334.3834.41
Upgrade
PS Ratio
4.583.872.356.385.003.54
Upgrade
PB Ratio
6.565.913.698.795.624.19
Upgrade
P/TBV Ratio
7.106.283.929.426.184.74
Upgrade
P/FCF Ratio
55.6154.0410.3037.88278.47-
Upgrade
P/OCF Ratio
29.0228.378.1027.6944.79-
Upgrade
EV/Sales Ratio
4.103.892.336.275.093.55
Upgrade
EV/EBITDA Ratio
13.7413.547.0120.6823.8724.41
Upgrade
EV/EBIT Ratio
15.4314.697.5022.5728.5532.19
Upgrade
EV/FCF Ratio
49.7054.2210.1837.22283.73-
Upgrade
Debt / Equity Ratio
0.230.120.140.160.200.26
Upgrade
Debt / EBITDA Ratio
0.540.270.260.360.801.44
Upgrade
Debt / FCF Ratio
1.951.100.390.679.87-
Upgrade
Asset Turnover
0.940.991.010.990.770.83
Upgrade
Inventory Turnover
0.871.071.101.140.951.34
Upgrade
Quick Ratio
0.920.831.041.351.101.48
Upgrade
Current Ratio
2.502.552.122.662.972.98
Upgrade
Return on Equity (ROE)
29.65%31.98%40.24%36.25%17.54%12.88%
Upgrade
Return on Assets (ROA)
15.55%16.34%19.68%17.23%8.63%5.75%
Upgrade
Return on Capital (ROIC)
20.36%22.81%27.88%22.69%10.95%7.21%
Upgrade
Earnings Yield
5.02%5.30%10.37%3.70%2.91%2.91%
Upgrade
FCF Yield
1.80%1.85%9.71%2.64%0.36%-2.59%
Upgrade
Dividend Yield
0.00%1.83%3.67%1.36%1.05%0.76%
Upgrade
Payout Ratio
34.21%40.54%25.55%13.80%15.89%11.25%
Upgrade
Buyback Yield / Dilution
0.51%3.50%-0.03%-0.37%-7.73%
Upgrade
Total Shareholder Return
2.35%7.16%1.33%0.67%-6.96%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.